title: New DNA sequencing technologies open a promising era for cancer research and treatment.
abstract: DNA sequencing techniques have evolved rapidly in the last 5 years by the introduction of new sequencing machines, denominated second-generation sequencers, next-generation sequencers or massive parallel sequencers. These technologies make it possible to determine the complete sequence of the human genome, or selected regions of it, at accessible prices and in a short period of time. Therefore, it is now possible to determine the nucleotide sequence of the DNA from cancer cells and to compare it to that of normal cells to identify the genetic changes involved in cancer generation. Actually, the genome of more than 15 tumour types has been determined in the last 3 years. The results obtained have allowed the identification of new cancer driving genes, new susceptibility genes and the detailed identification of genome structural reorganisations. In this review a brief description of the new sequencing technologies will be presented. Recent findings on cancer genome and exome sequencing will be summarised. Finally, the potential applications of these new technologies to cancer prognosis, diagnosis and therapeutics will be discussed.
authors: Instituto de Investigaciones Biomédicas CSIC/UAM, Instituto de Investigación Sanitaria del Hospital Universitario, La Paz (IdiPaz), Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain. Lsastre@iib.uam.es
authors: Leandro
authors: L
authors: Sastre
references: Nature. 2010 Oct 28;467(7319):1109-13
references: 20981101
references: PLoS One. 2010 Dec 22;5(12):e15661
references: 21203531
references: Science. 2009 Apr 10;324(5924):217
references: 19264984
references: Science. 2008 Sep 26;321(5897):1807-12
references: 18772396
references: Nature. 2010 Apr 15;464(7291):999-1005
references: 20393555
references: PLoS One. 2010 May 13;5(5):e10612
references: 20485525
references: Nucleic Acids Res. 2011 Jan;39(2):e8
references: 21059679
references: Nature. 2010 Jan 14;463(7278):184-90
references: 20016488
references: Nat Nanotechnol. 2009 Apr;4(4):265-70
references: 19350039
references: Nature. 2011 Feb 10;470(7333):214-20
references: 21307934
references: N Engl J Med. 2009 Sep 10;361(11):1058-66
references: 19657110
references: Science. 2010 Dec 3;330(6009):1410-3
references: 21051595
references: Nature. 2011 Jan 27;469(7331):539-42
references: 21248752
references: Curr Oncol. 2010 Oct;17(5):39-42
references: 20975877
references: Nature. 2010 May 27;465(7297):473-7
references: 20505728
references: Biochem Soc Trans. 2008 Oct;36(Pt 5):1091-6
references: 18793195
references: Nature. 2010 Jan 14;463(7278):191-6
references: 20016485
references: Genes Chromosomes Cancer. 2010 Nov;49(11):1062-9
references: 20725990
references: Nat Rev Genet. 2010 Jan;11(1):31-46
references: 19997069
references: Cancer Metastasis Rev. 2011 Jun;30(2):199-210
references: 21267768
references: Transl Res. 2009 Dec;154(6):277-87
references: 19931193
references: Leukemia. 2011 May;25(5):821-7
references: 21339757
references: Cell. 2011 Jan 7;144(1):27-40
references: 21215367
references: Genome Res. 2009 Jun;19(6):959-66
references: 19273618
references: Nat Biotechnol. 2008 Oct;26(10):1146-53
references: 18846088
references: Nat Genet. 2010 Nov;42(11):931-6
references: 20972442
references: Nature. 2008 Nov 6;456(7218):66-72
references: 18987736
references: Hum Mol Genet. 2009 Oct 15;18(R2):R163-8
references: 19808792
references: Mol Cancer. 2010 Jul 29;9:202
references: 20670437
references: Nat Rev Genet. 2010 Oct;11(10):685-96
references: 20847746
references: J Surg Res. 2012 Apr;173(2):365-9
references: 21195428
references: J Pathol. 2010 Sep;222(1):41-51
references: 20593407
references: Curr Opin Oncol. 2011 Jan;23(1):62-8
references: 21119514
references: Nature. 2009 Oct 8;461(7265):809-13
references: 19812674
references: Science. 2008 Sep 26;321(5897):1801-6
references: 18772397